It’s been over two years since the FDA started getting complaints about the failure of a hip replacement implant manufactured by DePuy Orthopaedics, a division of Johnson & Johnson. Over 93,000 people worldwide have had hip implant surgery with these devices, and the FDA has had over 400 complaints about it since 2008. Apparently, the failure happens early after surgery and a second, painful surgery is then required.
The high early failure rate of these implants (called ASR implants) has been known of for some time. ASR implants are part of a category of implants called metal-on-metal implants that cause debris from wear, inflammation and sometimes even tissue damage.
This is one of many recalls of many of Johnson & Johnson’s best-selling products. The giant pharmaceutical company is clearly in trouble – if you can call any pharmaceutical company whose earnings are down “in trouble.” The fact is, Big Pharma cleans up on meds and products. Last year, DePuy Orthopaedics had sales of almost $5.4 billion – and it’s just a division of J&J! I wonder if when asked what they wanted to be when they grew up in class, the leaders of these giants said, “I want to be the CEO of a huge pharmaceutical company that sells defective products and dangerous medications, and make a fortune doing it.”
For the full story, click "CONTINUE READING" below.